NAGE

NAGE Change in Working Capital

-$12.26MTTM · USD

Period ending:

NAGE FY Change in Working CapitalUSD
NAGE FY Change in Working Capital2007-11-30: -$101.002008-12-31: -$347.41K2009-12-31: -$88.41K2010-12-31: -$2.28M2011-12-31: $294.62K2012-12-31: -$1.51M2013-12-31: -$714.11K2014-12-31: -$511.99K2015-12-31: -$2.21M2016-12-31: -$2.77M2017-12-31: $2.01M2018-12-31: $5.19M2019-12-31: $427.00K2020-12-31: $1.08M2021-12-31: -$4.73M2022-12-31: -$6.01M2023-12-31: $4.62M2024-12-31: $3.13M2025-12-31: -$8.30M$5.19M-$8.30M
2007-11-302025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

NAGE change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 19 observations from Nov 30, 2007 to Dec 31, 2025.

Niagen Bioscience Inc Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-8,295,999
3,134,000
4,622,000
-6,014,000
-4,732,000
1,080,000
427,000
5,191,000
2,005,000
-2,765,249
-2,205,656
-511,990
-714,109
-1,506,510
294,624
-2,279,997
-88,408
-347,413
-101

Compare change in working capital

All NAGE financial metrics · NAGE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.